top of page
< Back

Tirzepatide (Mounjaro)

Combines GLP-1 and GIP receptor agonism to enhance weight loss by reducing appetite and improving blood sugar control.

Tirzepatide, the active ingredient in Mounjaro, is a dual-action medication that activates both GLP-1 and GIP receptors to reduce appetite and improve blood sugar control. This combination has been shown to provide superior weight loss results compared to other GLP-1 therapies.

This website is intended solely for providing information and should not be used as a source of medical advice. The products and treatments that are available on this site are not intended to diagnose, treat, cure, or prevent any disease. It is strongly recommended that you consult with your physician before starting any treatment or therapy program. All services offered on this site are provided under the supervision of a medical director. 

bottom of page